The Peripheral Benzodiazepine Receptor in Photodynamic Therapy with the Phthalocyanine Photosensitizer Pc 4¶

Abstract The peripheral benzodiazepine receptor (PBR) is an 18 kDa protein of the outer mitochondrial membrane that interacts with the voltage-dependent anion channel and may participate in formation of the permeability transition pore. The physiological role of PBR is reflected in the high-affinity binding of endogenous ligands that are metabolites of both cholesterol and heme. Certain porphyrin precursors of heme can be photosensitizers for photodynamic therapy (PDT), which depends on visible light activation of porphyrin-related macrocycles. Because the apparent binding affinity of a series of porphyrin analogs for PBR paralleled their ability to photoinactivate cells, PBR has been proposed as the molecular target for porphyrin-derived photocytotoxicity. The phthalocyanine (Pc) photosensitizer Pc 4 accumulates in mitochondria and structurally resembles porphyrins. Therefore, we tested the relevance of PBR binding on Pc 4–PDT. Binding affinity was measured by competition with 3H-PK11195, a high-affinity ligand of PBR, for binding to rat kidney mitochondria (RKM) or intact Chinese hamster ovary (CHO) cells. To assess the binding of the Pc directly, we synthesized 14C-labeled Pc 4 and found that whereas Pc 4 was a competitive inhibitor of 3H-PK11195 binding to the PBR, PK11195 did not inhibit the binding of 14C–Pc 4 to RKM. Further, 14C–Pc 4 binding to RKM showed no evidence of saturation up to 10 μM. Finally, when Pc 4–loaded CHO cells were exposed to activating red light, apoptosis was induced; Pc 4–PDT was less effective in causing apoptosis in a companion cell line overexpressing the antiapoptotic protein Bcl-2. For both cell lines, PK11195 inhibited PDT-induced apoptosis; however, the inhibition was transient and did not extend to overall cell death, as determined by clonogenic assay. The results demonstrate (1) the presence of low-affinity binding sites for Pc 4 on PBR; (2) the presence of multiple binding sites for Pc 4 in RKM and CHO cells other than those that influence PK11195 binding; and (3) the ability of high supersaturating levels of PK11195 to transiently inhibit apoptosis initiated by Pc 4–PDT, with less influence on overall cell killing. We conclude that the binding of Pc 4 to PBR is less relevant to the photocytotoxicity of Pc 4–PDT than are other mitochondrial events, such as photodamage to Bcl-2 and that the observed inhibition of Pc 4–PDT–induced apoptosis by PK11195 likely occurs through a mechanism independent of PBR.

[1]  N. Oleinick,et al.  Photodynamic Therapy-induced Apoptosis in Epidermoid Carcinoma Cells , 2001, The Journal of Biological Chemistry.

[2]  M. Pallàs,et al.  Further characterization of an adenosine transport system in the mitochondrial fraction of rat testis. , 2000, European journal of pharmacology.

[3]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[4]  M. Baraldi,et al.  Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. , 1998, Life sciences.

[5]  V. Papadopoulos,et al.  Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex , 1992, Molecular and Cellular Endocrinology.

[6]  V. Papadopoulos Structure and Function of the Peripheral-Type Benzodiazepine Receptor in Steroidogenic Cells , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[7]  S. Snyder,et al.  Molecular mechanisms of peripheral benzodiazepine receptors , 1990, Neurochemical Research.

[8]  Effect of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide (PK11195), a specific ligand of the peripheral benzodiazepine receptor, on the lipid fluidity of mitochondria in human glioma cells. , 1999, Biochemical pharmacology.

[9]  M. Mattei,et al.  Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. , 1991, European journal of biochemistry.

[10]  S. Snyder,et al.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. , 1999, Cancer research.

[12]  D. Rickwood,et al.  An evaluation of methods used to prepare yeast mitochondria for transcriptional studies. , 1984, Preparative biochemistry.

[13]  D. Kessel,et al.  Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. , 1999, Cancer research.

[14]  E. Matthews,et al.  Modification of the photodynamic action of delta-aminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands. , 1995, British Journal of Cancer.

[15]  H W Wang,et al.  Quantitative Analysis of Pc 4 Localization in Mouse Lymphoma (LY-R) Cells via Double-label Confocal Fluorescence Microscopy , 2000, Photochemistry and photobiology.

[16]  N. Oleinick,et al.  Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment. , 1998, Cancer research.

[17]  D. Williams,et al.  Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver. , 1996, Biochemical pharmacology.

[18]  Kevin M. Smith,et al.  The Role of the Peripheral Benzodiazepine Receptor in the Apoptotic Response to Photodynamic Therapy , 2001, Photochemistry and photobiology.

[19]  V. Papadopoulos,et al.  Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis. , 2001, International review of neurobiology.

[20]  H. Kohno,et al.  Involvement of peripheral-type benzodiazepine receptors in the intracellular transport of heme and porphyrins. , 1995, Journal of biochemistry.

[21]  P. Casellas,et al.  Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. , 1996, Blood.

[22]  S. Martin,et al.  The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. , 2001, Trends in biochemical sciences.

[23]  N. Oleinick,et al.  Phthalocyanine 4 photodynamic therapy-induced apoptosis of mouse L5178Y-R cells results from a delayed but extensive release of cytochrome c from mitochondria. , 2001, Cancer letters.

[24]  M. Baraldi,et al.  Increased expression of peripheral benzodiazepine receptors and diazepam binding inhibitor in human tumors sited in the liver. , 1999, Life sciences.

[25]  H. Yamamura,et al.  Peripheral-type benzodiazepine receptors. , 1993, Life sciences.

[26]  N. Oleinick,et al.  Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. , 2001, Experimental cell research.

[27]  S H Snyder,et al.  Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Kroemer,et al.  The mitochondrion in cell death control: certainties and incognita. , 2000, Experimental cell research.

[29]  G. Kroemer,et al.  Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. , 1999, Experimental cell research.

[30]  M. Kaufmann,et al.  Specific binding of benzodiazepines to human breast cancer cell lines. , 1999, Life sciences.

[31]  P. Ferrara,et al.  Characterization of a peripheral‐type benzodiazepine‐binding site in the mitochondria of Chinese hamster ovary cells , 1989, FEBS letters.

[32]  S H Snyder,et al.  The peripheral‐type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  G. Kroemer,et al.  Mitochondrion as a novel target of anticancer chemotherapy. , 2000, Journal of the National Cancer Institute.

[34]  N. Oleinick,et al.  Photodynamic therapy-induced apoptosis in lymphoma cells: translocation of cytochrome c causes inhibition of respiration as well as caspase activation. , 1999, Biochemical and biophysical research communications.

[35]  S H Snyder,et al.  Photodynamic Tumor Therapy: Mitochondrial Benzodiazepine Receptors as a Therapeutic Target , 1998, Molecular medicine.

[36]  G. Kroemer,et al.  Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore , 1999, Oncogene.

[37]  Abraham Weizman,et al.  Enigma of the peripheral benzodiazepine receptor. , 1999, Pharmacological reviews.

[38]  C. Iosif,et al.  Elevated concentrations of mitochondrial peripheral benzodiazepine receptors in ovarian tumors. , 1998, International journal of oncology.

[39]  G. Kroemer,et al.  PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. , 1998, Experimental cell research.

[40]  J. Alenfall,et al.  Characterization of peripheral benzodiazepine receptors in rat prostatic adenocarcinoma , 1994, The Prostate.

[41]  M. Kaufmann,et al.  Cell cycle-related expression and ligand binding of peripheral benzodiazepine receptor in human breast cancer cell lines. , 2000, European journal of cancer.

[42]  S. Snyder,et al.  Characterization of porphyrin interactions with peripheral type benzodiazepine receptors. , 1988, Molecular pharmacology.

[43]  A. Moor,et al.  Signaling pathways in cell death and survival after photodynamic therapy. , 2000, Journal of photochemistry and photobiology. B, Biology.

[44]  N. Oleinick,et al.  The photobiology of photodynamic therapy: cellular targets and mechanisms. , 1998, Radiation research.

[45]  D. Kessel,et al.  Mitochondrial photodamage and PDT-induced apoptosis. , 1998, Journal of photochemistry and photobiology. B, Biology.

[46]  M. McEnery,et al.  The mitochondrial benzodiazepine receptor: Evidence for association with the voltage-dependent anion channel (VDAC) , 1992, Journal of bioenergetics and biomembranes.

[47]  Liang-yan Xue,et al.  Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4 , 2001, Oncogene.

[48]  M. Kaufmann,et al.  Relation of cell proliferation to expression of peripheral benzodiazepine receptors in human breast cancer cell lines. , 2000, Biochemical pharmacology.

[49]  Nl Oleinick,et al.  The phothobiology of photodynamic therapy : cellular tagets and mechanisms , 1998 .

[50]  V. Papadopoulos,et al.  Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[51]  J. Hirsch,et al.  Characterization of ligand binding to mitochondrial benzodiazepine receptors. , 1989, Molecular pharmacology.

[52]  M. Agarwal,et al.  The Induction of Partial Resistance to Photodynamic Therapy by the Protooncogene BCL‐2 , 1996, Photochemistry and photobiology.

[53]  J. Herbert,et al.  Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. , 1999, Biochemical and biophysical research communications.

[54]  H. H. Evans,et al.  Differential antimutagenicity of WR-1065 added after irradiation in L5178Y cell lines. , 1999, Radiation research.

[55]  J. Hirsch,et al.  Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. , 1989, Molecular pharmacology.

[56]  S. Snyder,et al.  Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Gavish,et al.  Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. , 1999, Biochemical Pharmacology.

[58]  R. K. Pandey,et al.  Parabolic Quantitative Structure‐Activity Relationships and Photodynamic Therapy: Application of a Three‐Compartment Model with Clearance to the In Vivo Quantitative Structure‐Activity Relationships of a Congeneric Series of Pyropheophorbide Derivatives Used as Photosensitizers for Photodynamic Ther , 1999, Photochemistry and photobiology.

[59]  Q. Peng,et al.  Photodynamic Therapy , 1988, Methods in Molecular Biology.

[60]  Nancy L Oleinick,et al.  The role of apoptosis in response to photodynamic therapy: what, where, why, and how , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[61]  M. E. Kenney,et al.  NEW PHTHALOCYANINE PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY , 1993, Photochemistry and photobiology.